CSIMarket


Alkermes Plc   (ALKS)
Other Ticker:  
 


 

Alkermes Plc

ALKS's Financial Statements and Analysis



Alkermes Plc reported in the third quarter of 2023 net earnings per share of $0.28 an improvement compare to net loss per share of $-0.39 recorded a year ago and decline of -79.71 % from $1.38 earned in II. Quarter (Jun 30 2023).


third quarter of 2023
Earnings Per Share Revenues
$ 0.28 $  381 Mill
$+0.67     $+129M     +50.95 %



Alkermes Plc 's Revenue rose by 50.95 % in third quarter of 2023 (Sep 30 2023) year on year, to $381 million and declined by -38.3 % sequentially.


Alkermes Plc is

More on ALKS's Income Statement



Alkermes Plc 's net income of $47.758 million in the third quarter of 2023 increased from net loss of $-63.974 million III. Quarter a year ago.

Sequentially net earnings fell by -79.85 % from net income of $237.065 million realized in previous quarter.

More on ALKS's Growth

Alkermes Plc Inventories
Inventories grew by 15.57 % to $192 million from III. Quarter a year ago, sequentially inventories rose by 1.49 %. In Sep 30 2023 company's net cash and cash equivalents decreased by $-18 million, capital expenditures fell by -10.47437.99%, to $-14 millions compare to same quarter a year ago

More on ALKS's Cash flow Statement


Alkermes Plc does not pay out common stock dividend.

In trailing twelve-month period Alkermes Plc earned $ 1.72 cash per share, on a free-cash flow basis 138.47 % of net earning per share.

Book value grew by 5.65 % sequentially to $7.89 per share, 124% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 7.28 per share from $ 6.81.

Company issued 0.35 million shares or 0.20 % in Sep 30 2023.
Interest Coverage Ratio was 11. Debt Coverage Ratio was 0.82.

More on ALKS's Dividends

 Market Capitalization (Millions) 4,604
 Shares Outstanding (Millions) 172
 Total Debt (Millions $) 291
 Revenue (TTM) (Millions $) 1,591
 Net Income (TTM) (Millions $) 215
 Cash Flow (TTM) (Millions $) 384
 Capital Exp. (TTM) (Millions $) -41
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,500




Alkermes Plc does not pay out common stock dividend.

In trailing twelve-month period Alkermes Plc had $ 1.72 cash flow per share, on a free-cash flow basis 138.47 % of net earning per share.

Book value grew by 5.65 % sequentially to $7.89 per share, 124% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 7.28 per share from $ 6.81.

Company issued 0.35 million shares or 0.20 % in Sep 30 2023.
Interest Coverage Ratio was 11. Debt Coverage Ratio was 0.82.

More on ALKS's Balance Sheets

 Market Capitalization (Millions) 4,604
 Shares Outstanding (Millions) 172
 Total Debt (Millions $) 291
 Revenue (TTM) (Millions $) 1,591
 Net Income (TTM) (Millions $) 215
 Cash Flow (TTM) (Millions $) 384
 Capital Exp. (TTM) (Millions $) -41
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,500
   


  News about Alkermes Plc Earnings

Alkermes Plc: Surging Profits Amidst the Changing Tides of Pharmaceutical Industry



Alkermes Plc, a major player in the pharmaceutical preparations industry, has recently reported its financial results for the third quarter of fiscal year 2023. With positive bottom-line growth, increased revenue, improved profit margins, and notable developments in key financial indicators, the company appears to be on a positive trajectory. This article aims to analyze the impact of these results and explore the potential implications for Alkermes Plc moving forward.
1. Strong Financial Performance:
During the July to September 30, 2023 fiscal interval, Alkermes Plc achieved positive bottom-line growth, with a profit of $0.28 per share compared to a loss of $-0.39 per share in the same pe...

Alkermes Plc Showcases Remarkable 123.517% Revenue Jump Despite EPS Downturn in Q2 2023

Alkermes Plc: Strong Revenue Growth and Improved Profit Margins Boost Investor Confidence
Alkermes Plc, a leading biopharmaceutical company, has reported impressive financial results for the period ending June 30, 2023, showcasing a remarkable revenue growth of 123.517% year on year to reach $617.40 million. This substantial increase in revenue was driven by a doubling of revenue by 114.676%, reaching $287.60 million, compared to the previous reporting season.
One of the most significant developments for Alkermes Plc was the turnaround in income, as the company exhibited earnings per share of $1.38, in stark contrast to the preceding reporting season when net profit per share was at $-0.25. This posi...


Date modified: 2023-10-26T09:09:48+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com